Literature DB >> 5299159

[Clinical use of Kasugamycin for urinary tract infections due to Pseudomonas aeruginosa].

J Ishigami, Y Fukuda, S Hara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 5299159

Source DB:  PubMed          Journal:  J Antibiot B        ISSN： 0447-8991


× No keyword cloud information.
  2 in total

1.  Structural analysis of kasugamycin inhibition of translation.

Authors:  Barbara S Schuwirth; J Michael Day; Cathy W Hau; Gary R Janssen; Albert E Dahlberg; Jamie H Doudna Cate; Antón Vila-Sanjurjo
Journal:  Nat Struct Mol Biol       Date:  2006-09-24       Impact factor: 15.369

2.  Effects of Kasugamycin on the Translatome of Escherichia coli.

Authors:  Christian Lange; Matthias Lehr; Karolin Zerulla; Petra Ludwig; Jens Schweitzer; Tino Polen; Volker F Wendisch; Jörg Soppa
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.